Antonio Giordano

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Venues

The pharmacogenomics journal

Journal of Crohn's & colitis

This page only lists publications with an associated author ORCID identifier.

Publications

Juliana Salazar, Pau Riera, Jordi Gordillo, Albert Altès, Miguel Martínez, Montserrat Serès, Jordina Llaó, Antonio Giordano, Esther Garcia-Planella
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients. The pharmacogenomics journal 24 (4) (2024)
Juliana Salazar, Pau Riera, Jordi Gordillo, Albert Altès, Miguel Martínez, Montserrat Serès, Jordina Llaó, Antonio Giordano, Esther Garcia-Planella
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients. The pharmacogenomics journal 24 (4) (2024)
Antonio Giordano, Montserrat Rovira, Marisol Veny, Rebeca Barastegui, Pedro Marín, Carmen Martínez, Francesc Fernández-Avilés, María Suárez-Lledó, Ariadna Domènech, Anna Serrahima, Miquel Lozano, Joan Cid, Ingrid Ordás, Agnés Fernández-Clotet, Berta Caballol, Marta Gallego, Alejandro Vara, Maria Carme Masamunt, Àngel Giner, Iris Teubel, Miriam Esteller, Anna María Corraliza, Julian Panés, Azucena Salas, Elena Ricart
Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients. Journal of Crohn's & colitis (2024)
Juliana Salazar, Pau Riera, Jordi Gordillo, Albert Altès, Miguel Martínez, Montserrat Serès, Jordina Llaó, Antonio Giordano, Esther Garcia-Planella
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients. The pharmacogenomics journal 24 (4) (2024)

Antonio Giordano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Giordano